VISTAGEN THERAPEUTICS, INC. Interest Payable
VISTAGEN THERAPEUTICS, INC. (VTGN) had Interest Payable of $1.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities › Accrued Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2020-11-12
- 2020-09-30: Interest Payable $1.00K.
- 2020-06-30: Interest Payable $400.00.
- 2020-03-31: Interest Payable $0.00.
- 2019-12-31: Interest Payable $0.00.
| Period end | Interest Payable |
|---|---|
| 2020-09-30 | $1.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $400.00 10-Q · filed 2020-08-13 |
| 2020-03-31 | $0.00 10-Q · filed 2020-11-12 |
| 2019-12-31 | $0.00 10-Q · filed 2020-02-13 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-13 |
| 2019-03-31 | $0.00 10-Q · filed 2020-02-13 |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-12 |
| 2018-09-30 | $0.00 10-Q · filed 2018-10-29 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-14 |
| 2018-03-31 | $0.00 10-Q · filed 2019-02-12 |
| 2017-12-31 | $0.00 10-Q · filed 2018-02-12 |
| 2017-03-31 | $0.00 10-Q · filed 2018-02-12 |
| 2016-12-31 | $0.00 10-Q · filed 2017-02-13 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-12 |
| 2016-03-31 | $12.00K 10-Q · filed 2017-02-13 |
| 2015-03-31 | $260.70K 10-K · filed 2016-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |